Renate Parry
16Patents
4h-index
30Co-inventors
56Inventor score
Filing activity: Jul 8, 2003 → Sep 27, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8501185B2 | Dimeric molecular complexes | Chemistry; Metallurgy | 23 | Active |
| US7335748B2 | RG1 antibodies and uses thereof | Chemistry; Metallurgy | 14 | Expired |
| US9023351B2 | Anti-mesothelin antibodies and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US11103727B2 | Model based PBS optimization for flash therapy treatment planning and oncology information system | Physics | 6 | Active |
| US11173325B2 | Methods of use of ultra-high dose rate radiation and therapeutic agent | Emerging Cross-Sectional Technologies | 4 | Active |
| US11090508B2 | System and method for biological treatment planning and decision support | Human Necessities | 3 | Active |
| US9938583B2 | Biomarkers for radiation treatment | Physics | 3 | Active |
| US7307154B2 | DNA encoding a novel RG1 polypeptide | Human Necessities | 2 | Expired |
| US7608263B2 | RG1 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7611706B2 | RG1 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10844437B2 | Biomarkers for radiation treatment | Physics | 0 | Active |
| US7887804B2 | Methods for treating disease-states associated with RG1 using immunoconjugates | Human Necessities | 0 | Active |
| US11771920B2 | Methods of use of ultra-high dose rate radiation and therapeutic agent | Emerging Cross-Sectional Technologies | 0 | Active |
| US10602991B2 | Functional and physical imaging using radiation | Physics | 0 | Active |
| US7893217B2 | Isolated human antibodies that bind epitopes on RG1 | Human Necessities | 0 | Active |
| US12083356B2 | Model based PBS optimization for flash therapy treatment planning and oncology information system | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.